S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
NASDAQ:ARDS

Aridis Pharmaceuticals - ARDS News Today

$0.71
-0.09 (-11.25%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.64
$0.78
50-Day Range
$0.71
$1.50
52-Week Range
$0.57
$2.94
Volume
3.12 million shs
Average Volume
2.13 million shs
Market Capitalization
$14.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Get Aridis Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARDS and its competitors with MarketBeat's FREE daily newsletter.



ARDS Media Mentions By Week

ARDS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARDS
News Sentiment

0.10

0.72

Average
Medical
News Sentiment

ARDS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARDS Articles
This Week

8

0

ARDS Articles
Average Week

SourceHeadline
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP), Aridis Pharmaceuticals (ARDS) and Acurx Pharmaceuticals (ACXP)
markets.businessinsider.com - January 27 at 8:30 AM
MarketBeat logoHC Wainwright Cuts Aridis Pharmaceuticals (NASDAQ:ARDS) Price Target to $10.00
americanbankingnews.com - January 27 at 8:12 AM
msn.com logoAridis stock slumps ~25% as antibody drug fails phase 3 trial in pneumonia
msn.com - January 26 at 9:52 AM
finance.yahoo.com logoAridis Reports Top-Line Results of the Phase 3 Double-Blinded, Superiority Trial of AR-301 For the Treatment of Staphylococcus aureus Ventilator Associated Pneumonia (VAP)
finance.yahoo.com - January 25 at 6:34 PM
finance.yahoo.com logoNew Approaches to Treating Infections in Cystic Fibrosis Patients - AR 501 Phase 2 Trial Update
finance.yahoo.com - January 17 at 7:06 PM
finance.yahoo.com logoAridis Pharmaceuticals to Discuss Topline Data from Phase 3 Study of AR-301 During Corporate Update Call on January 25
finance.yahoo.com - December 28 at 1:24 PM
finance.yahoo.com logo(Updated) Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
finance.yahoo.com - December 12 at 5:26 PM
finance.yahoo.com logoAridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
finance.yahoo.com - December 12 at 7:32 AM
finance.yahoo.com logoAridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan-Ebola and Pan-Marburg Monoclonal Antibody Programs from Mapp Biopharmaceutical
finance.yahoo.com - December 5 at 3:43 PM
finance.yahoo.com logoAridis Announces a Key Milestone of Closing of Patient Enrollment in the Phase 2a Study of AR-501 in Cystic Fibrosis Patients
finance.yahoo.com - November 30 at 8:32 AM
finance.yahoo.com logoAridis to Participate in Key Opinion Leader Discussion on Immunotherapy for Infectious Diseases
finance.yahoo.com - November 22 at 4:37 PM
finanznachrichten.de logoAridis Pharmaceuticals, Inc.: Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update
finanznachrichten.de - November 22 at 3:06 AM
benzinga.com logoAridis Pharmaceuticals Late Monday Reported Q3 EPS $(0.47) Up From $(1.94) YoY, Sales $399.00K Down From $515.00K YoY
benzinga.com - November 22 at 3:06 AM
finance.yahoo.com logoAridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update
finance.yahoo.com - November 21 at 10:05 PM
finance.yahoo.com logoAridis Pharmaceuticals (ARDS) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 21 at 10:05 PM
finance.yahoo.com logoDICE Therapeutics (DICE) Up on Top-Line Data From Psoriasis Study
finance.yahoo.com - October 12 at 2:32 PM
finance.yahoo.com logoscPharmaceuticals (SCPH) Plunges Despite Furoscix's FDA Approval
finance.yahoo.com - October 11 at 11:02 PM
finance.yahoo.com logoAridis Announces the Closing of Patient Enrollment in the AR-301 Global Phase 3 Superiority Study
finance.yahoo.com - October 4 at 9:29 AM
finance.yahoo.com logoAridis Pharmaceuticals Announces Proposed Public Offering of Common Stock
finance.yahoo.com - September 26 at 7:21 PM
finance.yahoo.com logoWave Therapeutics (WVE) Up on Update From Huntington's Study
finance.yahoo.com - September 21 at 3:29 PM
seekingalpha.com logoARDS Aridis Pharmaceuticals, Inc.
seekingalpha.com - September 20 at 11:03 PM
finance.yahoo.com logobluebird's (BLUE) Gene Therapy Gets FDA Nod for CALD
finance.yahoo.com - September 19 at 2:18 PM
finance.yahoo.com logoIntellia (NTLA) Reports Positive Results for CRISPR Candidates
finance.yahoo.com - September 19 at 2:18 PM
uk.finance.yahoo.com logoAridis Pharmaceuticals, Inc. (ARDS)
uk.finance.yahoo.com - September 16 at 12:38 AM
seekingalpha.com logoAridis Pharmaceuticals GAAP EPS of -$0.45, revenue of $0.29M
seekingalpha.com - August 17 at 7:41 PM
finance.yahoo.com logoAridis Pharmaceuticals (ARDS) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 16 at 11:39 PM
finance.yahoo.com logoAridis Pharmaceuticals Announces Second Quarter 2022 Financial Results and Business Update
finance.yahoo.com - August 16 at 6:38 PM
finance.yahoo.com logoAridis' Inhaled Pan-Coronavirus Antibody Cocktail Shows Encouraging Preclinical Action
finance.yahoo.com - August 10 at 5:19 PM
finance.yahoo.com logoAridis' Pan-Coronavirus, Inhaled Monoclonal Antibody Cocktail AR-701 Is Protective in Non-Human Primates
finance.yahoo.com - August 10 at 12:18 PM
nasdaq.com logoHere's Why Aridis Pharmaceuticals (ARDS) Looks Ripe for Bottom Fishing
nasdaq.com - July 1 at 4:49 PM
apnews.com logoRedChip Interviews Aridis Pharmaceuticals’ CEO Vu Truong
apnews.com - July 1 at 11:48 AM
finance.yahoo.com logoRedChip Interviews Aridis Pharmaceuticals' CEO Vu Truong
finance.yahoo.com - June 30 at 10:31 AM
finance.yahoo.com logoAridis Pharmaceuticals CEO to Participate in a Fireside Chat Presented by Maxim Group LLC and Hosted by M-Vest on June 7
finance.yahoo.com - June 3 at 10:03 AM
finance.yahoo.com logoAridis Pharmaceuticals (ARDS) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 16 at 10:15 PM
finance.yahoo.com logoAridis Pharmaceuticals Announces First Quarter 2022 Financial Results and Business Update
finance.yahoo.com - May 16 at 5:14 PM
finance.yahoo.com logoAridis Pharma COVID-19 Antibody Neutralizes Omicron Variant In Animal Study
finance.yahoo.com - February 17 at 3:37 PM
seekingalpha.com logoAridis stock rises 6% as antibody cocktail AR-701 protects against Omicron in animal models
seekingalpha.com - February 17 at 10:36 AM
nasdaq.com logoWhy Aridis Pharma Is Rising In Pre-market?
nasdaq.com - February 17 at 10:36 AM
finance.yahoo.com logoAridis' Pan-Coronavirus Monoclonal Antibody Cocktail AR-701 Is Protective in COVID-19 Omicron Infected Animals
finance.yahoo.com - February 17 at 10:36 AM
seekingalpha.com logoWolfspeed, Galapagos, BlackBerry among premarket losers' pack
seekingalpha.com - January 31 at 9:19 AM
benzinga.com logoHow Is The Market Feeling About Aridis Pharmaceuticals Inc?
benzinga.com - January 28 at 1:57 PM
msn.com logoPeering Into Aridis Pharmaceuticals Inc's Recent Short Interest
msn.com - January 27 at 5:56 PM
finance.yahoo.com logoAridis Shares Rise On Funding For Inhaled Monoclonal Antibodies Against Influenza, COVID-19
finance.yahoo.com - January 27 at 12:51 PM
msn.com logoLooking Into Aridis Pharmaceuticals Inc's Recent Short Interest
msn.com - January 27 at 12:51 PM
msn.com logo(ARDS) - Analyzing Aridis Pharmaceuticals Inc's Short Interest
msn.com - January 27 at 12:51 PM
markets.businessinsider.com logoAridis Gets $1.9 Mln Funding From Gates Foundation To Fight Influenza, Covid-19 In Poor Countries
markets.businessinsider.com - January 27 at 7:51 AM
seekingalpha.com logoAridis wins funding from Gates Foundation to test inhalational COVID-19 antibodies
seekingalpha.com - January 27 at 7:51 AM
finance.yahoo.com logoAridis Pharmaceuticals Receives Funding to Evaluate Inhaled Monoclonal Antibodies to Block Influenza and SARS-CoV-2 Transmission
finance.yahoo.com - January 27 at 7:51 AM
markets.businessinsider.com logoPre-market Movers: KPRX, CTK, VGR, BVXV, NEW…
markets.businessinsider.com - December 30 at 7:44 AM
finance.yahoo.com logoH.C. Wainwright Bullish on Aridis Pharmaceuticals Covid-19 Antibody Cocktail
finance.yahoo.com - December 29 at 3:12 PM
Get Aridis Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARDS and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:ARDS) was last updated on 1/29/2023 by MarketBeat.com Staff